Updates on Laws, Regulations and Trends Impacting the Cannabis Industry
Updates on Laws, Regulations and Trends Impacting the Cannabis Industry
The push and pull on CBD regulation continues.
Earlier this week, Minnesota Representative Colin Peterson introduced a H.R. 5587, which would regulate CBD as a dietary supplement. Specifically, the bill would amend the federal Food, Drug, and Cosmetic Act…
Continue Reading
California’s Office of Environmental Health Hazard Assessment (OEHHA) has finalized the listing of “cannabis (marijuana) smoke” and delta-9-tetrahydrocannabinol (THC) as reproductive toxins under Proposition 65.
The listings are effective as of January 3, 2020. Under Prop 65, enforcement of the
In June 2019, the Illinois’ Cannabis Regulation and Tax Act (HR1438) (“Cannabis Act”) was signed into law, legalizing the use and possession of recreational cannabis for adults age 21 or older beginning January 1, 2020. In a previous Labor Days …
Continue Reading
On the latest episode of the Ad Law Access Podcast, partner Kristi Wolff discusses FDA’s recent CBD warning letters, Commissioner nominee Dr. Stephen Hahn’s confirmation hearings, and a preview of this week’s Cannabis Law Update webinar.
On Thursday, December…
Continue Reading
Cannabis is in the midst of a historic transformation from the black market to a regulated, lucrative, global industry. But investing in cannabis, or doing business with companies involved in cannabis production or distribution, comes with substantial legal and other…
Continue Reading
Kelley Drye’s Cannabis Law Practice is pleased to announce these upcoming educational opportunities:
On October 29, 2019, USDA released an interim final rule establishing the U.S. Domestic Hemp Production Program. The highly anticipated regulatory framework specifies the rules and regulations to produce hemp, as required by the 2018 Farm Bill. The interim rule…
Continue Reading
In an earlier blog post we informed readers that, in response to a mandamus petition of the Scottsdale Research Institute (SRI), the D.C. Circuit issued an order requiring the Drug Enforcement Administration (DEA) to explain why it allowed cannabis –…
Continue Reading
So imagine that your biggest pothead friend from college has opened up a cannabis dispensary that sells weed for recreational use. Your old pal would be selling something that remains utterly unlawful under federal law, the recent and sweeping changes…
Continue Reading
On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet…
Continue Reading
